I-Mab Biopharma
I-Mab Biopharma has developed TJM2, a neutralising antibody, as a treatment for patients suffering severe cases of the coronavirus infection.
Rankings by
National Ranking20th
in China Regional Ranking47th
in East Asia Global Ranking1125th
worldwide